Cutting edge: Hypoxia-induced nanog favors the intratumoral infiltration of regulatory T cells and macrophages via direct regulation of TGF-β1

Journal of Immunology

Volumn 191, Issue 12, 2013, Pages 5802-5806

  Hasmim, Meriem ^a   Noman, Muhammad Zaeem ^a   Messai, Yosra ^a   Bordereaux, Didier ^b   Gros, Gwendoline ^a   Baud, Veronique ^b   Chouaib, Salem ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DOPACHROME TAUTOMERASE; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR NANOG; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER INHIBITION; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL HYPOXIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; ENZYME REGULATION; IMMUNE DEFICIENCY; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MELANOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE;

EID: 84890378536     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302140     Document Type: Article

References (20)

1. Keith, B., R. S. Johnson, and M. C. Simon. 2012. HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression. Nat. Rev. Cancer 12: 9-22.
2. Mimeault, M., and S. K. Batra. 2013. Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells. J. Cell. Mol. Med. 17: 30-54.
3. Noman, M. Z., S. Buart, J. Van Pelt, C. Richon, M. Hasmim, N. Leleu, W. M. Suchorska, A. Jalil, Y. Lecluse, F. El Hage, et al. 2009. The cooperative induction of hypoxia-inducible factor-1α and STAT3 during hypoxia induced an impairment of tumor susceptibility to CTL-mediated cell lysis. J. Immunol. 182: 3510-3521.
4. Noman, M. Z., B. Janji, B. Kaminska, K. Van Moer, S. Pierson, P. Przanowski, S. Buart, G. Berchem, P. Romero, F. Mami-Chouaib, and S. Chouaib. 2011. Blocking hypoxia-induced autophagy in tumors restores cytotoxic T-cell activity and promotes regression. Cancer Res. 71: 5976-5986.
5. Hasmim, M., M. Z. Noman, J. Lauriol, H. Benlalam, A. Mallavialle, F. Rosselli, F. Mami-Chouaib, C. Alcaide-Loridan, and S. Chouaib. 2011. Hypoxia-dependent inhibition of tumor cell susceptibility to CTL-mediated lysis involves NANOG induction in target cells. J. Immunol. 187: 4031-4039.
6. Wang, M. L., S. H. Chiou, and C. W. Wu. 2013. Targeting cancer stem cells: emerging role of Nanog transcription factor. Onco Targets Ther. 6: 1207-1220.
7. Chouaib, S., Y. Messai, S. Couve, B. Escudier, M. Hasmim, and M. Z. Noman. 2012. Hypoxia promotes tumor growth in linking angiogenesis to immune escape. Front. Immunol. 3: 21.
8. Flavell, R. A., S. Sanjabi, S. H. Wrzesinski, and P. Licona-Limón. 2010. The polarization of immune cells in the tumour environment by TGFβ. Nat. Rev. Immunol. 10: 554-567.
9. Jacque, E., K. Billot, H. Authier, D. Bordereaux, and V. Baud. 2013. RelB inhibits cell proliferation and tumor growth through p53 transcriptional activation. Oncogene 32: 2661-2669.
10. Noh, K. H., B. W. Kim, K. H. Song, H. Cho, Y. H. Lee, J. H. Kim, J. Y. Chung, J. H. Kim, S. M. Hewitt, S. Y. Seong, et al. 2012. Nanog signaling in cancer promotes stem-like phenotype and immune evasion. J. Clin. Invest. 122: 4077-4093.
11. Mathieu, J., Z. Zhang, W. Zhou, A. J. Wang, J. M. Heddleston, C. M. Pinna, A. Hubaud, B. Stadler, M. Choi, M. Bar, et al. 2011. HIF induces human embryonic stem cell markers in cancer cells. Cancer Res. 71: 4640-4652.
12. + T cell responses. J. Immunol. 177: 8860-8873.
13. reg cells. Nature 475: 226-230.
14. Jauch, R., C. K. Ng, K. S. Saikatendu, R. C. Stevens, and P. R. Kolatkar. 2008. Crystal structure and DNA binding of the homeodomain of the stem cell transcription factor Nanog. J. Mol. Biol. 376: 758-770.
15. Mitsui, K., Y. Tokuzawa, H. Itoh, K. Segawa, M. Murakami, K. Takahashi, M. Maruyama, M. Maeda, and S. Yamanaka. 2003. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113: 631-642.
16. Yang, P., Q. J. Li, Y. Feng, Y. Zhang, G. J. Markowitz, S. Ning, Y. Deng, J. Zhao, S. Jiang, Y. Yuan, et al. 2012. TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. Cancer Cell 22: 291-303.
17. Köhler, T., B. Reizis, R. S. Johnson, H. Weighardt, and I. Förster. 2012. Influence of hypoxia-inducible factor 1α on dendritic cell differentiation and migration. Eur. J. Immunol. 42: 1226-1236.
18. Sun, Z., Q. Han, Y. Zhu, Z. Li, B. Chen, L. Liao, C. Bian, J. Li, C. Shao, and R. C. Zhao. 2011. NANOG has a role in mesenchymal stem cells' immunomodulatory effect. Stem Cells Dev. 20: 1521-1528.
19. Zhong, Z., K. D. Carroll, D. Policarpio, C. Osborn, M. Gregory, R. Bassi, X. Jimenez, M. Prewett, G. Liebisch, K. Persaud, et al. 2010. Anti-transforming growth factor β receptor II antibody has therapeutic efficacy against primary tumor growth and metastasis through multieffects on cancer, stroma, and immune cells. Clin. Cancer Res. 16: 1191-1205.
20. Byrne, S. N., M. C. Knox, and G. M. Halliday. 2008. TGFβ is responsible for skin tumour infiltration by macrophages enabling the tumours to escape immune destruction. Immunol. Cell Biol. 86: 92-97.